With the Sydney Marathon looming, this tech editor turns to Samsung’s AI running coach. Can this smart watch salvage a ...

Opthea investors are fighting over a smaller pool of cash after the failed eye drug developer reported $80 million of June quarter outflows.

The ASX found some momentum in the energy sector today, rising 0.08pc despite general anxieties over US tariff impacts.

Everest Metals’ gold projects promise near-term cashflow while its Mt Edon rubidium project has the potential to be truly ...

How an under-the-radar Aussie player is wiring up Asia’s smart cities, feeding AI with live data from half a million devices.

Island Pharmaceuticals hopes the US FDA will approve its acquired asset Galidesivir on the back of animal testing alone.

A desktop review and first-pass fieldwork identifies several iron-enriched rock chip samples at CuFe’s Camp Creek project in ...

Over a working life, a series of seemingly small choices can cost women up to $1m in lost earnings and wealth.

Phase 2 drilling by Ora Banda at the Davyhurst project expands the multi-lode gold system at Little Gem to a strike of more than 1km.

The RBA's monetary policy board “clearly remains nervous about inflation”, with a major bank warning a rate cut is not a lock in August.

The ASX lifted 0.11pc in the first hour this morning, gaining on a rising oil price and resulting strength in the energy sector.

Dimerix, Audeara, LTR Pharma and EZZ Life Science are among ASX health companies reporting quarterly results this week.